{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T09:04:02Z","timestamp":1793351042512,"version":"4.5.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T00:00:00Z","timestamp":1709683200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.bcp.2024.116114","type":"journal-article","created":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T12:09:45Z","timestamp":1726488585000},"page":"116114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Pharmacological inhibition of cathepsin S and of NSPs-AAP-1 (a novel, alternative protease driving the activation of neutrophil serine proteases)"],"prefix":"10.1016","volume":"229","author":[{"given":"Roxane","family":"Domain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seda","family":"Seren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Jerke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manousos","family":"Makridakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan-Ju","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Zoidakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moez","family":"Rhimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tillia","family":"Bonvent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Croix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lo\u00efc","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dedong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Basso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Paget","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Claude","family":"Viaud-Massuard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Lalmanach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Ping","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Aghdassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Vlahou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick P.","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Couillin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rich","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"Kettritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5159-8706","authenticated-orcid":false,"given":"Brice","family":"Korkmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.bcp.2024.116114_b0005","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.immuni.2021.06.006","article-title":"The neutrophil","volume":"54","author":"Burn","year":"2021","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.bcp.2024.116114_b0010","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1124\/pr.110.002733","article-title":"Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases","volume":"62","author":"Korkmaz","year":"2010","journal-title":"Pharmacol. Rev."},{"issue":"3","key":"10.1016\/j.bcp.2024.116114_b0015","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1124\/pr.115.012104","article-title":"Inhibitors and antibody fragments as potential anti-inflammatory therapeutics targeting neutrophil proteinase 3 in human disease","volume":"68","author":"Korkmaz","year":"2016","journal-title":"Pharmacol. Rev."},{"issue":"3","key":"10.1016\/j.bcp.2024.116114_b0020","doi-asserted-by":"crossref","first-page":"153","DOI":"10.5414\/CNP66153","article-title":"Production and applications of recombinant proteinase 3, wegener's autoantigen: problems and perspectives","volume":"66","author":"Jenne","year":"2006","journal-title":"Clin. Nephrol."},{"issue":"23","key":"10.1016\/j.bcp.2024.116114_b0025","doi-asserted-by":"crossref","first-page":"6570","DOI":"10.1093\/emboj\/20.23.6570","article-title":"Structure of human dipeptidyl peptidase I (cathepsin C): exclusion domain added to an endopeptidase framework creates the machine for activation of granular serine proteases","volume":"20","author":"Turk","year":"2001","journal-title":"EMBO J."},{"issue":"3","key":"10.1016\/j.bcp.2024.116114_b0030","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0021-9258(18)57294-X","article-title":"On the proteolytic enzymes of animal tissues; an intracellular enzyme related to chymotrypsin","volume":"174","author":"Gutmann","year":"1948","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2024.116114_b0035","first-page":"68","article-title":"Cysteine cathepsins: from structure, function and regulation to new frontiers","volume":"1824","author":"Turk","year":"2012","journal-title":"BBA"},{"issue":"11","key":"10.1016\/j.bcp.2024.116114_b0040","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0300-9084(97)83497-9","article-title":"Proregion structure of members of the papain superfamily. Mode of inhibition of enzymatic activity","volume":"79","author":"Cygler","year":"1997","journal-title":"Biochimie"},{"issue":"1\u20132","key":"10.1016\/j.bcp.2024.116114_b0045","first-page":"98","article-title":"Lysosomal cysteine proteases: more than scavengers","volume":"1477","author":"Turk","year":"2000","journal-title":"BBA"},{"issue":"5\u20136","key":"10.1016\/j.bcp.2024.116114_b0050","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/prca.201300085","article-title":"Cysteine cathepsins and their potential in clinical therapy and biomarker discovery","volume":"8","author":"Fonovic","year":"2014","journal-title":"Proteomics Clin. Appl."},{"issue":"8","key":"10.1016\/j.bcp.2024.116114_b0055","first-page":"2560","article-title":"Cysteine cathepsins and extracellular matrix degradation","volume":"1840","author":"Fonovic","year":"2014","journal-title":"BBA"},{"issue":"37","key":"10.1016\/j.bcp.2024.116114_b0060","doi-asserted-by":"crossref","first-page":"21626","DOI":"10.1074\/jbc.270.37.21626","article-title":"Oligomeric structure and substrate induced inhibition of human cathepsin C","volume":"270","author":"Dolenc","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2024.116114_b0065","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.pharmthera.2018.05.011","article-title":"Therapeutic targeting of cathepsin C: from pathophysiology to treatment","volume":"190","author":"Korkmaz","year":"2018","journal-title":"Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.bcp.2024.116114_b0070","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1021\/bi001693z","article-title":"Human recombinant pro-dipeptidyl peptidase I (cathepsin C) can be activated by cathepsins L and S but not by autocatalytic processing","volume":"40","author":"Dahl","year":"2001","journal-title":"Biochemistry"},{"issue":"16","key":"10.1016\/j.bcp.2024.116114_b0075","doi-asserted-by":"crossref","first-page":"8486","DOI":"10.1074\/jbc.M115.707109","article-title":"Neutrophilic cathepsin C is maturated by a multistep proteolytic process and secreted by activated cells during inflammatory lung diseases","volume":"291","author":"Hamon","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.bcp.2024.116114_b0080","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00281-013-0362-z","article-title":"Neutrophil proteinase 3 and dipeptidyl peptidase I (cathepsin C) as pharmacological targets in granulomatosis with polyangiitis (wegener granulomatosis)","volume":"35","author":"Korkmaz","year":"2013","journal-title":"Semin. Immunopathol."},{"issue":"3","key":"10.1016\/j.bcp.2024.116114_b0085","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1172\/JCI0213462","article-title":"Dipeptidyl peptidase I activates neutrophil-derived serine proteases and regulates the development of acute experimental arthritis","volume":"109","author":"Adkison","year":"2002","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.bcp.2024.116114_b0090","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/70525","article-title":"Loss-of-function mutations in the cathepsin C gene result in periodontal disease and palmoplantar keratosis","volume":"23","author":"Toomes","year":"1999","journal-title":"Nat. Genet."},{"issue":"32","key":"10.1016\/j.bcp.2024.116114_b0095","doi-asserted-by":"crossref","first-page":"12415","DOI":"10.1074\/jbc.RA118.001922","article-title":"Consequences of cathepsin C inactivation for membrane exposure of proteinase 3, the target antigen in autoimmune vasculitis","volume":"293","author":"Seren","year":"2018","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bcp.2024.116114_b0100","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/febs.13605","article-title":"Analysis of urinary cathepsin C for diagnosing papillon-lefevre syndrome","volume":"283","author":"Hamon","year":"2016","journal-title":"FEBS J."},{"issue":"19","key":"10.1016\/j.bcp.2024.116114_b0105","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20194747","article-title":"Processing and maturation of cathepsin C zymogen: a biochemical and molecular modeling analysis","volume":"20","author":"Lamort","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.bcp.2024.116114_b0110","doi-asserted-by":"crossref","first-page":"7277","DOI":"10.4049\/jimmunol.173.12.7277","article-title":"Papillon-Lefevre syndrome: correlating the molecular, cellular, and clinical consequences of cathepsin C\/dipeptidyl peptidase I deficiency in humans","volume":"173","author":"Pham","year":"2004","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.bcp.2024.116114_b0115","doi-asserted-by":"crossref","first-page":"708","DOI":"10.2174\/156802610791113469","article-title":"Therapeutic utility and medicinal chemistry of cathepsin C inhibitors","volume":"10","author":"Guay","year":"2010","journal-title":"Curr. Top. Med. Chem."},{"issue":"29","key":"10.1016\/j.bcp.2024.116114_b0120","doi-asserted-by":"crossref","first-page":"20836","DOI":"10.1074\/jbc.M702615200","article-title":"Inhibition of the activation of multiple serine proteases with a cathepsin C inhibitor requires sustained exposure to prevent pro-enzyme processing","volume":"282","author":"Methot","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2024.116114_b0125","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.bcp.2019.04.006","article-title":"Structure-based design and in vivo anti-arthritic activity evaluation of a potent dipeptidyl cyclopropyl nitrile inhibitor of cathepsin C","volume":"164","author":"Korkmaz","year":"2019","journal-title":"Biochem. Pharmacol."},{"issue":"5","key":"10.1016\/j.bcp.2024.116114_b0130","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1681\/ASN.2021081112","article-title":"Targeting cathepsin C in PR3-ANCA Vasculitis","volume":"33","author":"Jerke","year":"2022","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bcp.2024.116114_b0135","doi-asserted-by":"crossref","DOI":"10.1007\/s00011-023-01774-4","article-title":"BI 1291583: a novel selective inhibitor of cathepsin C with superior in vivo profile for the treatment of bronchiectasis","author":"Kreideweiss","year":"2023","journal-title":"Inflamm. Res."},{"issue":"20","key":"10.1016\/j.bcp.2024.116114_b0140","doi-asserted-by":"crossref","first-page":"9457","DOI":"10.1021\/acs.jmedchem.6b01127","article-title":"Discovery of second generation reversible covalent DPP1 inhibitors leading to an oxazepane amidoacetonitrile based clinical candidate (AZD7986)","volume":"59","author":"Doyle","year":"2016","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2024.116114_b0145","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12931-023-02444-z","article-title":"Dipeptidyl peptidase-1 inhibition with brensocatib reduces the activity of all major neutrophil serine proteases in patients with bronchiectasis: results from the WILLOW trial","volume":"24","author":"Cipolla","year":"2023","journal-title":"Respir. Res."},{"issue":"16","key":"10.1016\/j.bcp.2024.116114_b0150","doi-asserted-by":"crossref","first-page":"11857","DOI":"10.1021\/acs.jmedchem.1c00104","article-title":"Discovery and in vivo anti-inflammatory activity evaluation of a novel non-peptidyl non-covalent cathepsin C inhibitor","volume":"64","author":"Chen","year":"2021","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.bcp.2024.116114_b0155","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1021\/acs.joc.5b02628","article-title":"The synthesis of alpha, alpha-disubstituted alpha-amino acids via Ichikawa rearrangement","volume":"81","author":"Szczesniak","year":"2016","journal-title":"J. Org. Chem."},{"issue":"12","key":"10.1016\/j.bcp.2024.116114_b0160","doi-asserted-by":"crossref","first-page":"5901","DOI":"10.1021\/acs.jmedchem.9b00631","article-title":"Identification and optimization of novel cathepsin C inhibitors derived from EGFR inhibitors","volume":"62","author":"Hou","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2024.116114_b0165","doi-asserted-by":"crossref","first-page":"1185727","DOI":"10.3389\/fimmu.2023.1185727","article-title":"Brensocatib, an oral, reversible inhibitor of dipeptidyl peptidase 1, mitigates interferon-alpha-accelerated lupus nephritis in mice","volume":"14","author":"Chen","year":"2023","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.bcp.2024.116114_b0170","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00633-2022","article-title":"A phase 2 randomised study to establish efficacy, safety and dosing of a novel oral cathepsin C inhibitor, BI 1291583, in adults with bronchiectasis: airleaf","volume":"9","author":"Chalmers","year":"2023","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.bcp.2024.116114_b0175","doi-asserted-by":"crossref","first-page":"1239151","DOI":"10.3389\/fimmu.2023.1239151","article-title":"Dipeptidyl peptidase 1 inhibition as a potential therapeutic approach in neutrophil-mediated inflammatory disease","volume":"14","author":"Chalmers","year":"2023","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.bcp.2024.116114_b0180","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/nprot.2008.63","article-title":"Measuring elastase, proteinase 3 and cathepsin G activities at the surface of human neutrophils with fluorescence resonance energy transfer substrates","volume":"3","author":"Korkmaz","year":"2008","journal-title":"Nat. Protoc."},{"issue":"42","key":"10.1016\/j.bcp.2024.116114_b0185","doi-asserted-by":"crossref","first-page":"39074","DOI":"10.1074\/jbc.M202918200","article-title":"Discriminating between the activities of human neutrophil elastase and proteinase 3 using serpin-derived fluorogenic substrates","volume":"277","author":"Korkmaz","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"Pt 3","key":"10.1016\/j.bcp.2024.116114_b0190","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1042\/bj20020321","article-title":"Measurement of free and membrane-bound cathepsin G in human neutrophils using new sensitive fluorogenic substrates","volume":"366","author":"Attucci","year":"2002","journal-title":"Biochem. J."},{"key":"10.1016\/j.bcp.2024.116114_b0195","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.bcp.2017.02.009","article-title":"Prolonged pharmacological inhibition of cathepsin C results in elimination of neutrophil serine proteases","volume":"131","author":"Guarino","year":"2017","journal-title":"Biochem. Pharmacol."},{"issue":"7","key":"10.1016\/j.bcp.2024.116114_b0200","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/d41573-022-00071-9","article-title":"opnMe.com: a digital initiative for sharing tools with the biomedical research community","volume":"21","author":"Gollner","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"issue":"5","key":"10.1016\/j.bcp.2024.116114_b0205","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nmeth.1322","article-title":"Universal sample preparation method for proteome analysis","volume":"6","author":"Wisniewski","year":"2009","journal-title":"Nat. Methods"},{"issue":"1","key":"10.1016\/j.bcp.2024.116114_b0210","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00395-022-00934-7","article-title":"Cardioprotection by selective SGLT-2 inhibitors in a non-diabetic mouse model of myocardial ischemia\/reperfusion injury: a class or a drug effect?","volume":"117","author":"Nikolaou","year":"2022","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.bcp.2024.116114_b0215","unstructured":"J. Zoidakis, List of identified proteins in 6 biological replicates of HL-60 cells. Relative abundance of proteins in each sample are presented in ppm, 2023."},{"issue":"2","key":"10.1016\/j.bcp.2024.116114_b0220","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1136\/annrheumdis-2013-203717","article-title":"Cathepsin S inhibition suppresses systemic lupus erythematosus and lupus nephritis because cathepsin S is essential for MHC class II-mediated CD4 T cell and B cell priming","volume":"74","author":"Rupanagudi","year":"2015","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"10.1016\/j.bcp.2024.116114_b0225","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1021\/jm0201924","article-title":"Structure-activity relationship study and drug profile of N-(4-fluorophenylsulfonyl)-L-valyl-L-leucinal (SJA6017) as a potent calpain inhibitor","volume":"46","author":"Inoue","year":"2003","journal-title":"J. Med. Chem."},{"issue":"20","key":"10.1016\/j.bcp.2024.116114_b0230","doi-asserted-by":"crossref","first-page":"13800","DOI":"10.1074\/jbc.274.20.13800","article-title":"Molecular cloning and structural and functional characterization of human cathepsin F, a new cysteine proteinase of the papain family with a long propeptide domain","volume":"274","author":"Santamaria","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.bcp.2024.116114_b0235","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1515\/bchm3.1995.376.6.379","article-title":"Human cathepsin O2, a novel cysteine protease highly expressed in osteoclastomas and ovary molecular cloning, sequencing and tissue distribution","volume":"376","author":"Bromme","year":"1995","journal-title":"Bio. Chem. Hoppe-Seyler"},{"issue":"2","key":"10.1016\/j.bcp.2024.116114_b0240","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1006\/geno.1997.4631","article-title":"Structure and chromosomal assignment of the human cathepsin K gene","volume":"41","author":"Gelb","year":"1997","journal-title":"Genomics"},{"issue":"8","key":"10.1016\/j.bcp.2024.116114_b0245","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1021\/bi982175f","article-title":"Human cathepsin V functional expression, tissue distribution, electrostatic surface potential, enzymatic characterization, and chromosomal localization","volume":"38","author":"Bromme","year":"1999","journal-title":"Biochemistry"},{"issue":"2","key":"10.1016\/j.bcp.2024.116114_b0250","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1083\/jcb.100.2.535","article-title":"Processing and lysosomal localization of a glycoprotein whose secretion is transformation stimulated","volume":"100","author":"Gal","year":"1985","journal-title":"J. Cell Biol."},{"issue":"11","key":"10.1016\/j.bcp.2024.116114_b0255","doi-asserted-by":"crossref","first-page":"7066","DOI":"10.4049\/jimmunol.174.11.7066","article-title":"Asparagine endopeptidase is not essential for class II MHC antigen presentation but is required for processing of cathepsin L in mice","volume":"174","author":"Maehr","year":"2005","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.bcp.2024.116114_b0260","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1681\/ASN.2015020208","article-title":"Cathepsin S cleavage of protease-activated Receptor-2 on endothelial cells promotes microvascular diabetes complications","volume":"27","author":"Kumar Vr","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"10.1016\/j.bcp.2024.116114_b0265","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1161\/ATVBAHA.116.307786","article-title":"Neutrophil proteases promote experimental abdominal aortic aneurysm via extracellular trap release and plasmacytoid dendritic cell activation","volume":"36","author":"Yan","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.bcp.2024.116114_b0270","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12931-020-01381-5","article-title":"Cathepsin S: investigating an old player in lung disease pathogenesis, comorbidities, and potential therapeutics","volume":"21","author":"Brown","year":"2020","journal-title":"Respir. Res."},{"issue":"2","key":"10.1016\/j.bcp.2024.116114_b0275","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1164\/rccm.201906-1190PP","article-title":"Targeting proteases in cystic fibrosis lung disease. Paradigms, progress, and potential","volume":"201","author":"McKelvey","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.bcp.2024.116114_b0280","doi-asserted-by":"crossref","first-page":"6682657","DOI":"10.1155\/2021\/6682657","article-title":"Therapeutic inhibition of cathepsin S reduces inflammation and mucus plugging in adult betaENaC-tg mice","volume":"2021","author":"Brown","year":"2021","journal-title":"Mediators Inflamm."},{"issue":"1","key":"10.1016\/j.bcp.2024.116114_b0285","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1164\/rccm.201808-1518OC","article-title":"Protein phosphatase 2A reduces cigarette smoke-induced cathepsin S and loss of lung function","volume":"200","author":"Doherty","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.bcp.2024.116114_b0290","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1164\/rccm.201311-1986OC","article-title":"miR-31 dysregulation in cystic fibrosis airways contributes to increased pulmonary cathepsin S production","volume":"190","author":"Weldon","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"12","key":"10.1016\/j.bcp.2024.116114_b0295","doi-asserted-by":"crossref","first-page":"8106","DOI":"10.4049\/jimmunol.174.12.8106","article-title":"Role of cathepsin S-dependent epithelial cell apoptosis in IFN-gamma-induced alveolar remodeling and pulmonary emphysema","volume":"174","author":"Zheng","year":"2005","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.bcp.2024.116114_b0300","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/j.ajpath.2014.04.015","article-title":"Unopposed cathepsin G, neutrophil elastase, and proteinase 3 cause severe lung damage and emphysema","volume":"184","author":"Guyot","year":"2014","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.bcp.2024.116114_b0305","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1042\/bj2260233","article-title":"Human liver cathepsin L","volume":"226","author":"Mason","year":"1985","journal-title":"Biochem. J."},{"issue":"37","key":"10.1016\/j.bcp.2024.116114_b0310","doi-asserted-by":"crossref","first-page":"6487","DOI":"10.1021\/bi400925g","article-title":"Binding of chondroitin 4-sulfate to cathepsin S regulates its enzymatic activity","volume":"52","author":"Sage","year":"2013","journal-title":"Biochemistry"},{"issue":"14","key":"10.1016\/j.bcp.2024.116114_b0315","doi-asserted-by":"crossref","first-page":"4310","DOI":"10.1016\/j.bmc.2018.07.032","article-title":"Selective inhibition of human cathepsin S by 2,4,6-trisubstituted 1,3,5-triazine analogs","volume":"26","author":"Tber","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bcp.2024.116114_b0320","doi-asserted-by":"crossref","first-page":"6722","DOI":"10.1038\/ncomms7722","article-title":"Autoprocessing of neutrophil elastase near its active site reduces the efficiency of natural and synthetic elastase inhibitors","volume":"6","author":"Dau","year":"2015","journal-title":"Nat. Commun."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224000972?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224000972?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T17:15:08Z","timestamp":1741713308000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295224000972"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":64,"alternative-id":["S0006295224000972"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116114","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological inhibition of cathepsin S and of NSPs-AAP-1 (a novel, alternative protease driving the activation of neutrophil serine proteases)","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116114","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116114"}}